|
|
|
|
| |
CHRONOLOGY SINCE INCEPTION |
Last updated on 14/05/2008 |
| |
1958 : |
Debut of Square Pharma as a Partnership Firm. |
|
| |
1964 : |
Converted into a Private Limited Company. |
|
| |
1974 : |
Technical Collaboration with Janssen Pharmaceutica, Belgium, a subsidiary of Johnson and Johnson International, USA. |
|
| |
1982 : |
Licensing Agreement signed with F. Hoffmann-La Roche Ltd., Switzerland. |
|
| |
1985 : |
Achieved first position in the Pharmaceutical Market of Bangladesh among all national and multinational companies. |
|
| |
1987 : |
Pioneer in pharmaceutical export from Bangladesh. |
|
| |
1991 : |
Converted in to a Public Limited Company |
|
| |
1994 : |
Initial Public Offering of Square Pharmaceutical Shares. |
|
| |
1995 : |
Chemical Division of Square Pharmaceuticals Ltd. starts production of pharmaceutical bulk products (API). |
|
| |
1997 : |
Won the National Export trophy for exporting pharmaceuticals. |
|
| |
1998 : |
Agro-chemicals & Veterinary Products Division of Square Pharma starts its operation. |
|
| |
2001 : |
US FDA/UK MCA standard new Pharmaceutical factory goes into operation built under the supervision of Bovis Lend Lease, UK. |
|
| |
2004 : |
Signing of agreement with ROVIPHARM, Vietnam to manufacture and market SQUARE products under license in Vietnam.
|
|
| |
|
Secured the top position for the best published accounts and report for 2003 in the manufacturing category for transparency and excellence in corporate reporting. |
|
| |
2005 : |
New State-of- the-Art Square Cephlosporins Ltd. goes into operation; built under the supervision of TELSTAR S.A. of Spain as per US FDA/ UK MHRA requirements. |
|
| |
2007 : |
Square Pharmaceuticals Ltd., Dhaka Unit gets the UK MHRA approval. |
|
|
 |
|
